Vertaling van "consultative committee and a scientific committee as advisory " (Nederlands → Frans) :

The law of 20 July 2006 on the establishment and functioning of the FAMHP provides for the creation of a Transparency Committee, a Consultative Committee and a Scientific Committee as advisory bodies to the medicines agency.
The law of 20 July 2006 on the establishment and functioning of the FAMHP provides for the creation of a Transparency Committee, a Consultative Committee and a Scientific Committee as advisory bodies to the medicines agency.

determining the composition and functioning of the Scientific Committee, the Transparency Committee and the Consultative Committee established at the FAMHP and the various measures relating to the FAMHPS’s personnel, such as determining linguistic ratios and pension arrangements.
determining the composition and functioning of the Scientific Committee, the Transparency Committee and the Consultative Committee established at the FAMHP and the various measures relating to the FAMHPS’s personnel, such as determining linguistic ratios and pension arrangements.

Considerable attention was focused in 2007 on increased cooperation on the part of the FAMHP with the ethics committees, with the following results: ●● An interactive website with a web application that makes possible the “simple” management of communication actions between the different ethics committees, the FAMHP, the sponsors and researchers, and also monitors the different stages in the evaluation of each application by the ethics committees ●● Systematic consultation for the more complex scientific applications ●● Further optimisation of the functioning of
Considerable attention was focused in 2007 on increased cooperation on the part of the FAMHP with the ethics committees, with the following results: ●● An interactive website with a web application that makes possible the “simple” management of communication actions between the different ethics committees, the FAMHP, the sponsors and researchers, and also monitors the different stages in the evaluation of each application by the ethics committees ●● Systematic consultation for the more complex scientific applications ●● Further optimisation of the functioning of

Law of 20 July 2006 on the establishment and functioning of the Federal Agency for Medicines and Health Products Royal decrees of 25 February 2007 on the composition and working method of the committees of the Federal Agency for Medicines and Health Products Royal decree of 20 December 2007 determining the date of establishment of the Scientific Committee, namely 1 February 2008 Royal decree of 28 January 2008 on the concrete composition of the Consultative Committee Ministerial decree of 11 January 2007 on the composition and appointment of the members of the executive board of the Federal Agency for Medicines and Health Products
Law of 20 July 2006 on the establishment and functioning of the Federal Agency for Medicines and Health Products Royal decrees of 25 February 2007 on the composition and working method of the committees of the Federal Agency for Medicines and Health Products Royal decree of 20 December 2007 determining the date of establishment of the Scientific Committee, namely 1 February 2008 Royal decree of 28 January 2008 on the concrete composition of the Consultative Committee Ministerial decree of 11 January 2007 on the composition and appointment of the members of the executive board of the Federal Agency for Medicines and Health Products

Advisory commission which is consulted e.g. in cases of non-availability of medicines Commission for the approval of institutions assigning preliminary approvals for scientific events Commission for the establishment of retail pharmacies and chambers of appeal (Frenchspeaking chamber and Dutch-speaking chamber) Commission for the recognition of pharmacists-clinical biologists Commission for the supervision of advertising for medicines for human use Evaluation commission for active implantable medical devices Evaluation commission for homeopathic medicines Evaluation commission for medical devices Evaluation commission for medicines for human use Evaluation commission for medicines for veterinary use Evaluation commission for traditional herbal medicines Pharmacopoeia commission
Advisory commission which is consulted e.g. in cases of non-availability of medicines Commission for the approval of institutions assigning preliminary approvals for scientific events Commission for the establishment of retail pharmacies and chambers of appeal (Frenchspeaking chamber and Dutch-speaking chamber) Commission for the recognition of pharmacists-clinical biologists Commission for the supervision of advertising for medicines for human use Evaluation commission for active implantable medical devices Evaluation commission for homeopathic medicines Evaluation commission for medical devices Evaluation commission for medicines for human use Evaluation commission for medicines for veterinary use Evaluation commission for traditional herbal medicines Pharmacopoeia commission

Advisory commission that is consulted e.g. in cases of non-availability of medicines Commission for the approval of institutions assigning preliminary approvals for scientific events Commission for the establishment of retail pharmacies and chambers of appeal (French-speaking chamber and Dutch-speaking chamber) Commission for the recognition of pharmacistsclinical biologists Commission for the supervision of advertising for medicines for human use
Advisory commission that is consulted e.g. in cases of non-availability of medicines Commission for the approval of institutions assigning preliminary approvals for scientific events Commission for the establishment of retail pharmacies and chambers of appeal (French-speaking chamber and Dutch-speaking chamber) Commission for the recognition of pharmacistsclinical biologists Commission for the supervision of advertising for medicines for human use

In the same train of thought, a very recent report of the Committee on Toxicity of Chemicals in Food, an independent scientific advisory body in the United Kingdom, shows the state of affairs concerning the potential toxicity of caffeine in pregnant women and affirms, with great circumspection, that caffeine is already likely to affect the development of the foetus from a daily consumption of 200 mg (COT, 2008).
Dans le même ordre d’idées, un rapport très récent du Comité de Toxicologie du Royaume-Uni, organisme indépendant de conseil scientifique, fait un nouveau point sur la possible toxicité de la caféine chez la femme enceinte et déclare, avec beaucoup de précautions, qu’il est vraisemblable que la caféine affecte le développement du fœtus déjà pour des apports journaliers de l’ordre de 200 mg (COT, 2008).

Scientific Advisory Committee van de European
membre du Scientific Advisory Committee